You're reading the free version. Trader adds the live tape and alerts.
Start tracking
UTHR Sale Disclosure
Rothblatt Martine A · SEC Form 4 · Filed Nov 5, 2026
Sale
Calculated transaction value
$49.05K
Rothblatt Martine A Chairperson & CEO
UTHR
Transaction date
Nov 4, 2026
Public filing date
Nov 5, 2026
Filing lag
Filed 1 day later
UTHR daily price context
Close on/before transaction
$608.49
Nov 4, 2026
First close after public filing
$562.02
Nov 6, 2026
Return after filing · so far
+5.99%
Through Nov 11, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 80 shares @ $613.13
- SEC ownership
- Indirect
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001106578-26-000180
Filing cohort
Transactions in this filing
Showing 4 of 4
Trades
4
Issuers
1
Estimated value
$1.05M
Buys / sales
0 / 4
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| United Therapeutics Corp UTHR | Sale | Nov 4, 2026 | $246.34K |
| United Therapeutics Corp UTHR | Sale | Nov 4, 2026 | $513.87K |
| United Therapeutics Corp UTHR | Sale | Nov 4, 2026 | $243.6K |
| United Therapeutics Corp UTHR Current | Sale | Nov 4, 2026 | $49.05K |